Minor RAS
MINOR
in this group, there were 17 minor RAS subjects, with mean USS score prior treatment of 29.2 ± 3.9 (range 22–36). After 3 months therapy, the USS improved by 29.2% to a mean of 20.7 (p < 0.0001) (Table 